Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stem cells in Rapidly Evolving Active Multiple Sclerosis (STREAMS)
2012-002357-35Phase 2Completed
- Sponsor
- Imperial College London
- Start
- Jul 2012
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2 trial of autologous mesenchymal stem cells in multiple sclerosis (MS), sponsored by Imperial College London. Primary endpoint: Co-primary objectives. Started Jul 2012; status: completed.
02
Drugs
autologous mesenchymal stem cells
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2012-002357-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002357-35.